Patent Assignment
Reel/Frame 021893/0640
Assignment of Assignor's Interest
Recorded: 2008-11-26
Pages: 114
Assignor
BAYER PHARMACEUTICALS CORPORATION
Executed: 2007-11-13
Assignee
BAYER HEALTHCARE LLC
555 WHITE PLAINS ROAD, TARRYTOWN, NEW YORK, 10591
Covered Properties
(10)
Heteroaryl Ureas Containing Nitrogen Hetero-Atoms as P38 Kinase Inhibitors
Application:
09/838,286 →
Publication:
US 2002/0065296
Aryl urea compounds in combination with other cytostatic or cytotoxic agents for treating human cancers
Application:
10/308,187 →
Publication:
US 2003/0232765
Pyridine, Quinoline, and Isoquinoline N-Oxides as Kinase Inhibitors
Application:
10/361,850 →
Publication:
US 2003/0216396
Aryl Ureas as Kinase Inhibitors
Methods for prediction and prognosis of cancer, and monitoring cancer therapy
Application:
10/675,406 →
Publication:
US 2004/0121375
2-Oxo-1,3,5-Perhydrotriazapine Derivatives Useful in the Treatment of Hyper-Proliferative, Angiogenesis, and Inflammatory Disorders
Novel Bicyclic Urea Derivatives Useful in the Treatment of Cancer and Other Disorders
Substituted Pyridine Derivatives Useful in the Treatment of Cancer and Other Disorders
Application:
10/789,446 →
Publication:
US 2004/0229937
Inhibition of Raf Kinase Using Quinolyl, Isoquinolyl or Pyridyl Ureas
Aryl urea compounds in combination with other cytostatic or cytotoxic agents for treating human cancers
Application:
11/480,360 →
Publication:
US 2006/0247186
Related Assignments
(4)
Other recorded transfers of the patents in this record — the chain of ownership.
Assignment of Assignor's Interest
Oct 19, 2004
From: BOYER, STEPHEN; DUMAS, JACQUES; PHILLIPS, BARTON; SCOTT, WILLIAM J.
To: BAYER PHARMACEUTICAL CORPORATION
Reel/Frame 015898/0826 →
Assignment of Assignor's Interest
Oct 28, 2004
From: DUMAS, JACQUES; BOYER, STEPHEN; VERMA, SHARAD; ADNANE, LILA
To: BAYER PHARMACEUTICAL CORPORATION
Reel/Frame 015925/0710 →
Assignment of Assignor's Interest
Feb 25, 2005
From: BAYER CORPORATION
To: BAYER PHARMACEUTICALS CORPORATION
Reel/Frame 016313/0371 →
Assignment of Assignor's Interest
Jul 27, 2009
From: BAYER PHARMACEUTICALS CORPORATION
To: BAYER HEALTHCARE LLC
Reel/Frame 023031/0963 →